Artcline

Rostock, Germany

Artcline is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine.

$5.9M raised

Sep 2025

Convertible Note

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Artcline

How much funding has Artcline raised?

Artcline has raised $5.9M in total funding. The most recent round was Convertible Note. The last funding was announced in September 2025.

Where is Artcline headquartered?

Artcline is headquartered in Rostock, Germany.

What does Artcline do?

Artcline is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine.

What stage is Artcline at?

Artcline is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 9, 2025.

MLA

"Artcline — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/artcline. Accessed June 17, 2026.

APA

VCBacked. (2025). Artcline — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/artcline

Wikipedia (cite web)

{{cite web |title=Artcline — Funding & Investors |url=https://www.vcbacked.co/company/artcline |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 9, 2025.